ABIRISK Developments and Challenges: Perspectives from Year 2

The Innovative Medicine Initiative’s Anti-Biopharmaceutical Immunization: Prediction and analysis of clinical relevance to minimize the risk (ABIRISK) project has made significant progress in its second year. This presentation will provide an overview of current developments with a focus on anti-drug antibody and neutralizing antibody assays provided for the analysis of retrospective and prospective cohorts.